Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions. (Q37165515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Thomas A. Kent

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Pitchaiah Mandava

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1019-1028

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-200868080-00001

7 January 2020

exact match

0 references

cites work

Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868080-00001

The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868080-00001

Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868080-00001

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868080-00001

Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidence

21 January 2018

1 reference

12 December 2020

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile

1 reference

12 December 2020

Time Is Brain--Quantified

1 reference

12 December 2020

Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor

1 reference

12 December 2020

Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding

1 reference

12 December 2020

Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion

1 reference

12 December 2020

Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia

1 reference

12 December 2020

Rescue treatment with abciximab in acute ischemic stroke.

1 reference

12 December 2020

Fatal hemorrhagic transformation of acute cerebral infarction after the use of abciximab

1 reference

12 December 2020

Glanzmann's thrombasthenia: the spectrum of clinical disease

1 reference

12 December 2020

The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial

1 reference

12 December 2020

Tissue plasminogen activator for acute ischemic stroke

1 reference

12 December 2020

Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention

1 reference

12 December 2020

Dissociation between the anti-aggregatory & anti-secretory effects of platelet integrin alpha IIb beta 3 (GPIIb/IIIa) antagonists, c7E3 and DMP728

1 reference

12 December 2020

Inhibition of dog platelet function by in vivo infusion of F(ab')2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor

1 reference

12 December 2020

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

1 reference

12 December 2020

Changes in membrane glycoproteins of circulating platelets after coronary stent implantation

1 reference

12 December 2020

Glycoprotein IIb/IIIa antagonists--from bench to practice

1 reference

12 December 2020

Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study

1 reference

12 December 2020

Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study.

1 reference

12 December 2020

Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy

1 reference

12 December 2020

Lacunar infarction: embolism is the key: against.

1 reference

12 December 2020

Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial

1 reference

12 December 2020

Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial

1 reference

12 December 2020

Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study)

1 reference

12 December 2020

Structure and function of the platelet integrin alphaIIbbeta3

1 reference

12 December 2020

Facilitated angioplasty: paradise lost

1 reference

12 December 2020

Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study

1 reference

12 December 2020

Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention

1 reference

12 December 2020

Lacunar infarction: embolism is the key.

1 reference

12 December 2020

Platelet receptors for adenine nucleotides and thromboxane A2

1 reference

12 December 2020

Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke tre

1 reference

12 December 2020

Platelet function in acute myocardial infarction treated with direct angioplasty

1 reference

12 December 2020

An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates

1 reference

12 December 2020

Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab

1 reference

12 December 2020

Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors

1 reference

12 December 2020

Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial Infarction

1 reference

12 December 2020

Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases

1 reference

12 December 2020

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.

1 reference

12 December 2020

Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor.

1 reference

12 December 2020

Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation

1 reference

12 December 2020

Anti-GPIIb/IIIa drugs: current strategies and future directions

1 reference

12 December 2020

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)

1 reference

12 December 2020

Clinical aspects of platelet inhibitors and thrombus formation

1 reference

12 December 2020

Initial safety experience of abciximab and heparin for acute ischemic stroke.

1 reference

12 December 2020

Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions

1 reference

12 December 2020

Intra-arterial therapies for acute ischemic stroke

1 reference

12 December 2020

Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics

1 reference

12 December 2020

Reversal of dense signs predicts recovery in acute ischemic stroke.

1 reference

12 December 2020

MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window

1 reference

12 December 2020

Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans

1 reference

12 December 2020

Integrins: dynamic scaffolds for adhesion and signaling in platelets

1 reference

12 December 2020

Platelet physiology and thrombosis.

1 reference

12 December 2020

10.2165/00003495-200868080-00001

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484795%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 January 2020

0 references

1 reference